Tetsuro Sekine1, Felipe de Galiza Barbosa2, Felix P Kuhn3, Irene A Burger2, Paul Stolzmann4, Gerhard F Huber5, Spyros S Kollias6, Gustav K von Schulthess2, Patrick Veit-Haibach7, Martin W Huellner2. 1. Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Switzerland; Department of Radiology, Nippon Medical School, Tokyo, Japan. Electronic address: tetsuro.sekine@gmail.com. 2. Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Switzerland. 3. Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland; Clinic of Neuroradiology, University Hospital Zurich, University of Zurich, Switzerland. 4. Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Switzerland; Clinic of Neuroradiology, University Hospital Zurich, University of Zurich, Switzerland. 5. Department of Otorhinolaryngology, University Hospital Zurich, University of Zurich, Switzerland. 6. Clinic of Neuroradiology, University Hospital Zurich, University of Zurich, Switzerland. 7. Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Switzerland; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland.
Abstract
PURPOSE: To compare the diagnostic accuracy of PET+MR with PET/CT in the initial staging of head and neck cancer. MATERIALS AND METHODS: Contrast-enhanced PET/CT+MR was performed in 27 patients with newly diagnosed head and neck cancer. PET/CT and PET+MR were evaluated separately, and the TNM stage and factors influencing treatment were assessed. RESULTS: The TNM staging by PET+MR was comparable to PET/CT (T: p=0.331, N: p=0.453, M: p=0.034). The sensitivity/specificity/accuracy of treatment-influencing factors by PET/CT and PET+MR were 0.68/0.99/0.97, and 1.00/1.00/0.99, respectively. CONCLUSIONS: Whole-body staging with PET+MR yields at least equal diagnostic accuracy as PET/CT in head and neck cancer.
PURPOSE: To compare the diagnostic accuracy of PET+MR with PET/CT in the initial staging of head and neck cancer. MATERIALS AND METHODS: Contrast-enhanced PET/CT+MR was performed in 27 patients with newly diagnosed head and neck cancer. PET/CT and PET+MR were evaluated separately, and the TNM stage and factors influencing treatment were assessed. RESULTS: The TNM staging by PET+MR was comparable to PET/CT (T: p=0.331, N: p=0.453, M: p=0.034). The sensitivity/specificity/accuracy of treatment-influencing factors by PET/CT and PET+MR were 0.68/0.99/0.97, and 1.00/1.00/0.99, respectively. CONCLUSIONS: Whole-body staging with PET+MR yields at least equal diagnostic accuracy as PET/CT in head and neck cancer.
Authors: Christian M Meerwein; Martin Hüllner; Ralph Braun; Michael B Soyka; Grégoire B Morand; David Holzmann Journal: Eur Arch Otorhinolaryngol Date: 2019-05-16 Impact factor: 2.503
Authors: Lisa W Lekanne Dit Deprez; Grégoire B Morand; Christian Thüring; Shila Pazahr; Martin W Hüllner; Martina A Broglie Journal: Eur Arch Otorhinolaryngol Date: 2021-11-15 Impact factor: 2.503
Authors: Alexander Maurer; Christian M Meerwein; Michael B Soyka; Hannes Grünig; Stephan Skawran; Urs J Mühlematter; Michael Messerli; Cäcilia E Mader; Lars Husmann; Niels J Rupp; David Holzmann; Martin W Huellner Journal: Head Neck Date: 2021-09-13 Impact factor: 3.821
Authors: Grégoire B Morand; Domenic G Vital; Ken Kudura; Jonas Werner; Sandro J Stoeckli; Gerhard F Huber; Martin W Huellner Journal: Sci Rep Date: 2018-08-07 Impact factor: 4.379